Price $117.11 |
Market Cap
1.54B
|
Sector Health Care |
Div. Growth
-100.00%
|
|
P/E
47.8
|
P/B
5.54
|
P/S
3.62
|
Dividend %
1.20%
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-
|
FCF
-
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-
|
ROI
17.80%
|
|
ROA
-
|
EPS Growth
-
|
Current Ratio
0.9
|
Debt/Equity
6.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bausch Health Companies Inc (BHC) | $29.54 | - | - | 10.52B | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $68.73 | - | 2.90% | 148.62B | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $6.53 | - | - | 15.2M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.80 | - | - | 97.6M | Strong Buy |
| Opiant Pharmaceuticals Inc (OPNT) | $15.13 | - | - | 60.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
